Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 11  |  Issue : 6  |  Page : 168--172

Lower serum levels of bilirubin in the newly diagnosed lung cancer patients: A case-control study in China


Qian Song1, Bing Wang2, Sheng Wang3, Yi-Min Zhang3, Wen-Hu Chen1 
1 Department of Clinical Laboratory, Zhejiang Cancer Hospital, Zhejiang Key Laboratory of Radiation Oncology, Beijing 100049, China
2 Department of Clinical Laboratory, Aerospace Central Hospital, Haidian, Beijing 100049, China
3 Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang, Beijing 100049, China

Correspondence Address:
Wen-Hu Chen
Zhejiang Key Laboratory of Diagnosis and Treatment Technology Research on Chest Tumor (Lung, Esophagus), 38 Guangji Road, Hangzhou 310022, Zhejiang
China

Purpose: A few prospective studies demonstrated that bilirubin levels were inversely associated with the risk of lung cancer. However, the retrospective study about the relationship between bilirubin levels and lung cancer in China was not available. So, we want to know whether there has a difference in serum bilirubin concentrations between normal people and lung cancer patients. Materials and Methods: Using a case-control study, we investigated the bilirubin levels in 317 patients with lung cancer and 317 age-, sex-matched controls from Zhejiang Cancer Hospital. Furthermore, we analyzed the associations between serum bilirubin expressions and baseline clinical features of lung cancer patients using a Wilcoxon rank sum test. Results: Bilirubin levels, including total bilirubin, direct bilirubin, and indirect bilirubin, were significantly lower in human lung cancer serum relative to normal control (P < 0.001), and the older (>50 years) had higher bilirubin levels compared with the younger (27–50 years) in lung cancer group. Besides, the duration of smoking was negatively related to bilirubin levels, but they did not reach statistical significance except for indirect bilirubin (P = 0.041). However, there was no difference in bilirubin levels between small cell lung cancer (SCLC) and non-SCLC (NSCLC), and we did not find that the bilirubin levels were correlated with sex, drinking status in patients of lung cancer. Conclusion: Serum total bilirubin, indirect bilirubin, and direct bilirubin levels of the patients with lung cancer were all significantly lower than those of control group (P < 0.001). Lower levels of bilirubin may be a risk factor for lung cancer, and it could serve as a potential screening biomarker for lung cancer. Large-scale investigations and additional improvements are urgently needed to demonstrate the mechanism and molecular pathway in order to achieve the clinical utility in the future.


How to cite this article:
Song Q, Wang B, Wang S, Zhang YM, Chen WH. Lower serum levels of bilirubin in the newly diagnosed lung cancer patients: A case-control study in China.J Can Res Ther 2015;11:168-172


How to cite this URL:
Song Q, Wang B, Wang S, Zhang YM, Chen WH. Lower serum levels of bilirubin in the newly diagnosed lung cancer patients: A case-control study in China. J Can Res Ther [serial online] 2015 [cited 2022 Sep 28 ];11:168-172
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2015;volume=11;issue=6;spage=168;epage=172;aulast=Song;type=0